While angiogenesis in the adult brain is classically considered quiescent under physiological conditions, mounting evidence from pathological contextssuch as stroke, trauma, glioma, and multiple sclerosisdemonstrates that angiogenic reactivation can occur in response to stress or injury (Thomsen et al
In a 48-week Phase 2 trial published in the New England Journal of Medicine (Sanyal and colleagues, NCT04771273), 293 adults with biopsy-confirmed MASH and fibrosis stage F1 through F3 were randomized 1:1:1:1 to once-weekly subcutaneous survodutide at 2.4, 4.8, or 6.0 mg or placebo, again using a 24-week rapid escalation followed by a 24-week maintenance phase
The Endgame Several trajectories are converging
Factors influencing results include: Injury severity: Minor strains may resolve quickly while chronic degenerative conditions require longer protocols
5-Amino-1MQ is a peptide that researchers believe helps improve metabolism